Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Lung Neoplasms 12 Brain Neoplasms 12 Depression 7 Carcinoma, Hepatocellular 7 Pain 6 Colonic Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Prostatic Neoplasms 5 Leiomyoma 5 Head and Neck Neoplasms 5 Agnosia 5 Ovarian Neoplasms 4 Multiple Myeloma 4 Delirium 4 Colorectal Neoplasms 4 Anxiety Disorders 4 Supratentorial Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Myofibroma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3 Emergence Delirium 3 Chronic Pain 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

pembrolizumab 12 Radiotherapy 9 avelumab 8 Nivolumab 8 cemiplimab 4 Radiation 4 Ipilimumab 4 poly ICLC 3 atezolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Cyclophosphamide 3 talimogene laherparepvec 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 Carboplatin 2 Biopsy 2 veliparib 1 vatalanib 1 tremelimumab 1 tocilizumab 1 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Merkel Cell × Saline Solution × Clear all

NCT03271372 2026-05-12

ADAM

University of Washington

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡